PEG-coated liposomes
1 abstract
Abstract
The design, preclinical study and phase I dose escalation plan of a HER2 targeted immunoliposome (HF-K1) for HER2 low solid tumor treatment.Org: Hangzhou HighField Biopharmaceuticals Corporation, Zhejiang University, School of Pharmacy,